We are live on
!
Find out more
WCMN
Westchester Capital Management (Nebraska) Portfolio holdings
AUM
$555M
1-Year Est. Return
50.73%
This Fund
S&P 500
This Quarter
Est. Return
+13.77%
1 Year Est. Return
+50.73%
3 Year Est. Return
+107.07%
5 Year Est. Return
+146.12%
10 Year Est. Return
+436.97%
AUM
$317M
AUM Growth
+$35M
(+12%)
Cap. Flow
+$228K
Cap. Flow
% of AUM
0.07%
Top 10 Holdings %
Top 10 Hldgs %
48.74%
Holding
56
New
12
Increased
9
Reduced
23
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$556K |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$350K |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$350K |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$350K |
| 5 |
Conagra Brands
CAG
|
+$260K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$414K |
| 2 |
Apple
AAPL
|
+$353K |
| 3 |
ExxonMobil
XOM
|
+$270K |
| 4 |
Caterpillar
CAT
|
+$243K |
| 5 |
Microsoft
MSFT
|
+$185K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.99% |
| 2 | Healthcare | 23.61% |
| 3 | Industrials | 13.25% |
| 4 | Financials | 10.91% |
| 5 | Communication Services | 8.83% |
Similar funds
TAWM
TC
CAM
QL
TPA
TCM
CA
CFP
Westchester Capital Management (Nebraska)'s Q4 2020 Portfolio in Review
As of Q4 2020, Westchester Capital Management (Nebraska) held 56 positions worth $317M, up 12% from $282M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Westchester Capital Management (Nebraska)'s Q4 2020 filing shows 12 new, 9 increased, 23 reduced and 1 closed positions. Its largest new stake was Viatris: 34,088 shares worth $639K. The largest sale was Pfizer, an estimated $414K.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
- Westchester Capital Management (Nebraska)'s largest Q4 2020 buy was Viatris: 34,088 shares worth $639K.
- Westchester Capital Management (Nebraska) added most to Vanguard Short-Term Treasury ETF in Q4 2020, an estimated $350K increase.
- Westchester Capital Management (Nebraska)'s biggest Q4 2020 reduction was Pfizer, cutting an estimated $414K.
- Westchester Capital Management (Nebraska) fully exited Synchrony in Q4 2020, selling an estimated $58K.
- Westchester Capital Management (Nebraska)'s ten largest holdings make up 49% of its $317M portfolio in Q4 2020.
- Westchester Capital Management (Nebraska) opened 12 new positions and closed 1 in Q4 2020.
- Westchester Capital Management (Nebraska)'s portfolio value rose 12% quarter-over-quarter to $317M.
Based on Westchester Capital Management (Nebraska)'s 13F filing for Q4 2020, filed 8 Feb 2021.